TECH (Bio-Techne) 3-Year Book Growth Rate: 2.70% (As of Jun. 2026) — 81% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TECH Bio-Techne Corp TECH
87 GF Score
Price $72.37
GF Value $71.27
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bio-Techne 3-Year Book Growth Rate?

Bio-Techne TECH -0.07% 87 3-Year Book Growth Rate is 2.70% as of Jun. 2026, which is 81% below its 10-year median of 13.90. GuruFocus rates TECH with a GF Score™ of 87/100 and a GF Value™ of $71.27 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,123 Biotechnology companies, Bio-Techne ranks better than 66.87% on this metric.

Bio-Techne's Book Value per Share for the quarter that ended in Jun. 2026 was $13.51.

During the past 12 months, Bio-Techne's average Book Value per Share Growth Rate was 9.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 2.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 5.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Bio-Techne was 49.40% per year. The lowest was 2.70% per year. And the median was 13.90% per year.


Bio-Techne  (NAS:TECH) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Bio-Techne 3-Year Book Growth Rate Related Terms


TECH vs SMMT, HALO, ARWR: 3-Year Book Growth Rate Comparison

For the Biotechnology subindustry, Bio-Techne's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne 3-Year Book Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Bio-Techne's 3-Year Book Growth Rate falls into.


TECH
87GF Score
Bio-Techne Corp TECH
3-Year Book Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

What does a 3-Year Book Growth Rate of 2.70% mean?
Bio-Techne (TECH) has a 3-Year Book Growth Rate of 2.70% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Bio-Techne and its competitors. This is 81% below median its historical median of 13.90. Over the past decade, Bio-Techne's 3-Year Book Growth Rate has ranged from 2.70 to 49.40. According to the industry distribution chart, Bio-Techne ranks #372 out of 1123 companies in the Biotechnology industry, placing it in the top 33.1%.
Is Bio-Techne's 3-Year Book Growth Rate too high?
Bio-Techne's current 3-Year Book Growth Rate of 2.70% is 81% below median its 10-year median of 13.90. Over the past 10 years, this metric has ranged from a low of 2.70 to a high of 49.40. Based on the distribution chart, Bio-Techne ranks #372 out of 1123 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bio-Techne has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's 3-Year Book Growth Rate compare to SMMT and HALO?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #372 out of 1123 companies for 3-Year Book Growth Rate. This puts Bio-Techne in the upper half of its industry. Historically, Bio-Techne's own 3-Year Book Growth Rate has ranged from 2.70 to 49.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Bio-Techne and its competitors. Bio-Techne's current 3-Year Book Growth Rate is 2.70%, which is 81% below median its own 10-year median of 13.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Based on GuruFocus' analysis, Bio-Techne (TECH) is currently considered Fairly Valued. The stock's GF Value™ is $71.27, compared to a current price of $72.37 — trading 1.5% above its estimated fair value. The current 3-Year Book Growth Rate is 2.70%, which is 81% below median its 10-year median of 13.90. Bio-Techne's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Bio-Techne (TECH), the current 3-Year Book Growth Rate is 2.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be overvalued. The current stock price of $72.37 is trading 1.5% above its estimated GF Value™ of $71.27. GuruFocus considers Bio-Techne to be Fairly Valued.

Key valuation signals for TECH:

  • 3-Year Book Growth Rate: 2.70% (81% below median its 10-year median of 13.90)
  • GF Value™: $71.27 vs. price of $72.37 (1.5% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Techne Business Description

Other Exchanges TE1:GermanyT1CH34:Brazil
Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
87GF Score

Get the complete analysis for TECH

3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.37
Price
$71.27
GF Value